You are on page 1of 37

20152231

2015612



3.4

20
29

305918

10
30-17.135-23.440-20.145-22.850-17.355-17.560-15.965-15.2

20062060
40505559
200210
20-0.125-0.630-1.235-2.240-4.145-4.450-5.555-5.560-5.265-4.7

200.6307.04012.55021.1

QOL

10

10



510


cancer survivors,


1000500(201



By medicina vol48 no13. 2011-12.


HBV

HPV

by

I
B(2014)

CXR+

CT

HPV

40X
50

40

40

20

40

B
40C
I

http://canscreen.ncc.go.jp/guideline/matome.html


HBV
COPDCT

. medicina 201112 ( Vol.48 No.13)

20122013
http://ganjoho.jp/public/statistics/pub/statistics01.html

(25
http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/geppo/nengai13/dl/gaikyou25.pdf

http://blog.livedoor.jp/gp_ken/archives/3830324.html

II(7)2012
http://goo.gl/RxZDcr

http://www.1ginzaclinic.com/cancer-survivor.html
http://www.yhmf.jp/pdf/activity/adstudies/vol_36_04.pdf
. medicina 201112 ( Vol.48 No.13)

http://ganjoho.jp/public/pre_scr/prevention/evidence_based.html

http://www.igaku-shoin.co.jp/journalDetail.do?journal=33918

http://canscreen.ncc.go.jp/guideline/matome.html

DrSlideShare

http://www.slideshare.net/hiroshiiga/presentations

You might also like